Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid.

Health Minister Dinesh Gundu Rao told the Assembly on Thursday that the government is seeking compensation for the bereaved families. “A child has lost its mother. We can’t let this go. Though compensation cannot bring back lives, the company must be held liable,” Rao said.

The deaths occurred at Ballari District Hospital in November. A medical panel from Rajiv Gandhi University of Health Sciences has ruled out medical negligence, pointing to the Ringer’s Lactate solution manufactured by Paschim Banga as the suspected cause.

Multiple batches of the IV fluid failed quality tests in Karnataka laboratories. Drug Controllers in five districts – Shivamogga, Chikkamagaluru, Haveri, Bengaluru, and Gadag – have filed complaints in jurisdictional courts between December 7-9.

In Shivamogga, charges have been filed under Sections 18(a)(i) and 27(d) of the Drugs and Cosmetics Act. The offences carry imprisonment between one to two years and a minimum fine of Rs 20,000 for manufacturing and selling substandard or spurious drugs.

Related Posts

  • Pharma
  • March 17, 2025
  • 16 views
Sun Pharma, Zydus recall products in US

The US Food and Drug Administration (USFDA) has said that Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues. In its latest Enforcement…

  • Pharma
  • March 17, 2025
  • 57 views
Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte

Strides Pharma shares gained 2.8 per cent on BSE, logging an intraday high at Rs 603 per share in Tuesday’s trade. The buying interest sparked after the company arm Strides…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma, Zydus recall products in US

Sun Pharma, Zydus recall products in US

Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte

Strides Pharma gains 3% as Singapore arm acquires 100% stake in Amexel Pte

Licensing delays pushing medical device makers abroad: Parliament panel

Licensing delays pushing medical device makers abroad: Parliament panel

1471 drugs samples manufactured in HP failed quality tests in past two years

1471 drugs samples manufactured in HP failed quality tests in past two years